Back to companies

Cogent Biosciences Inc: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Cogent Biosciences Inc (Cogent Biosciences) is a clinical-stage biotechnology company that develops therapies for genetically defined diseases. The company’s pipeline products include Bezuclastinib (CGT9486), for the treatment of non-advanced systemic mastocytosis, advanced systemic mastocytosis and gastrointestinal stromal tumors; CGT1145 treats Myeloproliferative Neoplasms; CGT4255 which targets breast cancer and non-small cell lung cancer; CGT6297 for the treatment of breast cancer; and CGT1815 treats solid tumors. It operates offices in Massachusetts and Colorado, the US. Cogent Biosciences is headquartered in Waltham, Massachusetts, the US.

 Gain a 360-degree view of Cogent Biosciences Inc and make more informed decisions for your business Gain a 360-degree view of Cogent Biosciences Inc and make more informed decisions for your business Register your interest
Headquarters United States of America
Address 4th Floor, 180 Third Avenue, Waltham, Massachusetts, 02451
Website www.cogentbio.com
Telephone 1 617 9455576
No of Employees 258
Industry Pharmaceuticals and Healthcare
Ticker Symbol & Exchange COGT (NASD)
EPS XYZ
Net Income (2024) XYZ -28.6% (2024 vs 2023)
Market Cap* $6.9B
Net Profit Margin (0 vs) XYZ 0.0% (2024 vs 2023)
   
* As of and is in US$
View Cogent Biosciences Inc financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Register your interest

Products and Services

Products
Pipeline
Bezuclastinib (CGT9486):
Non-Advanced Systemic Mastocytosis (Non-AdvSM)
XYZ
XYZ
XYZ
Understand Cogent Biosciences Inc portfolio and identify potential areas for collaboration Understand Cogent Biosciences Inc portfolio and identify potential areas for collaboration Register your interest
Image for loader

Competitor Comparison

Key Parameters Cogent Biosciences Inc Novartis AG GSK plc Amgen Inc Incyte Corp
Headquarters United States of America Switzerland United Kingdom United States of America United States of America
City Waltham Basel London Thousand Oaks Wilmington
State/Province Massachusetts Basel-Stadt England California Delaware
No. of Employees 258 75,267 66,841 31,500 2,844
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Register your interest
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Register your interest
Executives
Name Position Board Since Age
Peter Harwin Chairman Executive Board - 40
Andrew Robbins Director; Chief Executive Officer; President Executive Board 2020 50
John Green Chief Financial Officer Senior Management 2020 45
Brad Barnett Chief Technology Officer Senior Management 2020 -
Evan Kearns Secretary; Chief Legal Officer Senior Management 2021 45
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Cogent Biosciences Inc key executives to enhance your sales strategy Gain insight into Cogent Biosciences Inc key executives to enhance your sales strategy Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?